Literature DB >> 7195140

Investigations on the interaction between cyproheptadine and amphetamine.

D Cenajek, A Chodera, J Godlewski, Z Wójciak.   

Abstract

The effect of cyproheptadine (CPH) given in doses of 1.25 and 5 mg/kg intraperitoneally one hour before administration of D-(+)-amphetamine (AMPH) 5 mg/kg subcutaneously was studied. A moderate increase was observed in the intensity of amphetamine-induced stereotypy and a significant rise in the number of rearings after premedication with CPH 5 mg/kg. In pharmacokinetic investigations the serum level of AMPH was found to be decreased in the animals after CPH premedication. The biological half-time of AMPH in the blood was reduced after premedication with CPH 5 mg/kg. On the other hand, the level of amphetamine rose in the brain following premedication with CPH in both doses. These results suggest that the rise in brain AMPH level could be responsible for intensification of AMPH effects induced by CPH premedication.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7195140

Source DB:  PubMed          Journal:  Acta Physiol Pol        ISSN: 0044-6033


  1 in total

1.  The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function.

Authors:  Olivia A Lin; Zubair A Karim; Hari Priya Vemana; Enma V P Espinosa; Fadi T Khasawneh
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.